{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:45:58Z","timestamp":1785919558676,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present study investigated the therapeutic potential of quercetin nanoparticles (QNPs), administered alone or in combination with levodopa\/carbidopa (L\/C), against reserpine-induced neurochemical alterations and motor dysfunction in a rat model of Parkinson\u2019s disease (PD). Animals were randomly assigned to five experimental groups: a control group, a reserpine-induced PD group, and PD groups treated with QNPs, L\/C, or their combination. Motor performance was assessed using the open-field and grid traction tests. Reserpine administration induced marked motor impairments accompanied by significant reductions in dopamine (DA), serotonin (5-HT), and norepinephrine (NE) levels in both the striatum and midbrain. These neurochemical deficits were associated with elevated monoamine oxidase (MAO) activity, increased lipid peroxidation (malondialdehyde, MDA), enhanced acetylcholinesterase (AChE) activity, and increased nitric oxide (NO) levels in both brain regions. Additionally, reduced glutathione (GSH) levels were decreased in the midbrain but elevated in the striatum. Treatment with QNPs significantly restored monoamine levels and normalized MAO and AChE activities. Moreover, QNPs markedly attenuated oxidative stress and improved motor performance in reserpine-treated rats. Similarly, L\/C administration effectively reversed monoamine depletion, normalized enzymatic activities, and mitigated oxidative stress. Notably, combined treatment with QNPs and L\/C produced effects comparable to those observed with either treatment alone, suggesting a lack of additive or synergistic interaction. These findings demonstrate that QNPs exert a significant neuroprotective effect against reserpine-induced motor dysfunction and neurochemical disturbances, supporting their potential as a therapeutic strategy for Parkinsonian pathology.<\/jats:p>","DOI":"10.1038\/s41598-026-63820-5","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:35:08Z","timestamp":1785915308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin nanoparticles exhibit a potential therapeutic effect against the neurochemical changes and motor deficits in a rat model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Hend","family":"El-bakry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser A.","family":"Khadrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim H.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-9514","authenticated-orcid":false,"given":"Haitham S.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"1","key":"63820_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","volume":"208","author":"MG Tansey","year":"2007","unstructured":"Tansey, M. G., McCoy, M. K. & Frank-Cannon, T. C. Neuroinflammatory mechanisms in Parkinson\u2019s disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp. Neurol. 208 (1), 1\u201325. https:\/\/doi.org\/10.1016\/j.expneurol.2007.07.004 (2007).","journal-title":"Exp. Neurol."},{"key":"63820_CR2","doi-asserted-by":"publisher","unstructured":"Tansey, M. G. et al. Neuroinflammation in Parkinson\u2019s disease: Is there sufficient evidence for mechanism-based interventional therapy? Front. Biosci. J. Virtual Libr. 13, 709\u2013717. (2008). https:\/\/doi.org\/10.2741\/2713","DOI":"10.2741\/2713"},{"issue":"4","key":"63820_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/mds.21751","volume":"23","author":"PL McGeer","year":"2008","unstructured":"McGeer, P. L. & McGeer, E. G. Glial reactions in Parkinson\u2019s disease. Mov. Disorders Off. J. Mov. Disorder Soc. 23 (4), 474\u2013483. https:\/\/doi.org\/10.1002\/mds.21751 (2008).","journal-title":"Mov. Disorders Off. J. Mov. Disorder Soc."},{"key":"63820_CR4","doi-asserted-by":"publisher","unstructured":"Mucci, S., Herrera, M. I., Barreto, G. E., Kolliker-Frers, R. & Capani, F. Neuroprotection in hypoxic-ischemic brain injury targeting glial cells. Curr. Pharm. Design. https:\/\/doi.org\/10.2174\/1381612823666170727145422 (2017).","DOI":"10.2174\/1381612823666170727145422"},{"key":"63820_CR5","doi-asserted-by":"publisher","unstructured":"Chiurchi\u00f9, V., Orlacchio, A. & Maccarrone, M. Is Modulation of oxidative stress an answer? The state of the art of redox therapeutic actions in neurodegenerative diseases. Oxidative Med. Cell. Longev. https:\/\/doi.org\/10.1155\/2016\/7909380 (2016).","DOI":"10.1155\/2016\/7909380"},{"key":"63820_CR6","doi-asserted-by":"publisher","first-page":"2525967","DOI":"10.1155\/2017\/2525967","volume":"2017","author":"Z Liu","year":"2017","unstructured":"Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P. & Zuo, L. Oxidative stress in neurodegenerative diseases: From molecular mechanisms to clinical applications. Oxidative Med. Cell. Longev. 2017, 2525967. https:\/\/doi.org\/10.1155\/2017\/2525967 (2017).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"63820_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cbi.2017.03.016","volume":"269","author":"C Anusha","year":"2017","unstructured":"Anusha, C., Sumathi, T. & Joseph, L. D. Protective role of apigenin on rotenone induced rat model of Parkinson\u2019s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis. Chemico-Biol. Interact. 269, 67\u201379. https:\/\/doi.org\/10.1016\/j.cbi.2017.03.016 (2017).","journal-title":"Chemico-Biol. Interact."},{"key":"63820_CR8","doi-asserted-by":"publisher","unstructured":"Kouli, A., Torsney, K. M. & Kuan, W. L. Parkinson\u2019s Disease: Etiology, neuropathology, and pathogenesis. In Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects 3\u201326 (Codon Publications, 2018). https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"10","key":"63820_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00210-019-01672-9","volume":"392","author":"DP Wang","year":"2019","unstructured":"Wang, D. P. et al. Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 392 (10), 1277\u20131284. https:\/\/doi.org\/10.1007\/s00210-019-01672-9 (2019).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"63820_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","volume":"1704","author":"F Rahmani","year":"2019","unstructured":"Rahmani, F. et al. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. Brain Res. 1704, 127\u2013136. https:\/\/doi.org\/10.1016\/j.brainres.2018.10.006 (2019).","journal-title":"Brain Res."},{"issue":"8","key":"63820_CR11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes, O. B. & Storstein, A. Epidemiology of Parkinson\u2019s disease. J. Neural Transm. 124 (8), 901\u2013905. https:\/\/doi.org\/10.1007\/s00702-017-1686-y (2017).","journal-title":"J. Neural Transm."},{"key":"63820_CR12","doi-asserted-by":"publisher","unstructured":"Ou, Z. et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s Disease in 204 Countries\/Territories From 1990 to 2019. Front. Public. Health. https:\/\/doi.org\/10.3389\/fpubh.2021.776847 (2021).","DOI":"10.3389\/fpubh.2021.776847"},{"issue":"44","key":"63820_CR13","doi-asserted-by":"publisher","first-page":"e27511","DOI":"10.1097\/MD.0000000000027511","volume":"100","author":"Y Wang","year":"2021","unstructured":"Wang, Y., Jiang, D. Q., Lu, C. S., Li, M. X. & Jiang, L. L. Efficacy and safety of combination therapy with pramipexole and levodopa vs levodopa monotherapy in patients with Parkinson\u2019s disease. Medicine 100 (44), e27511. https:\/\/doi.org\/10.1097\/MD.0000000000027511 (2021).","journal-title":"Medicine"},{"key":"63820_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuro.2022.03.004","volume":"90","author":"SS Josiah","year":"2022","unstructured":"Josiah, S. S. et al. Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1\u03b2, TNF-\u03b1, NF-\u03baB, I\u03baKB, and p53 genes in male Wistar rats. NeuroToxicology 90, 158\u2013171. https:\/\/doi.org\/10.1016\/j.neuro.2022.03.004 (2022).","journal-title":"NeuroToxicology"},{"key":"63820_CR15","doi-asserted-by":"publisher","first-page":"2986796","DOI":"10.1155\/2016\/2986796","volume":"2016","author":"L G Costa","year":"2016","unstructured":"G Costa, L., M Garrick, J., J Roqu\u00e8, P. & Pellacani, C. Mechanisms of neuroprotection by quercetin: Counteracting oxidative stress and more. Oxidative Med. Cell. Longev. 2016, 2986796. https:\/\/doi.org\/10.1155\/2016\/2986796 (2016).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"63820_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/J.TIFS.2021.11.032","volume":"119","author":"K Kandemir","year":"2022","unstructured":"Kandemir, K., Tomas, M., McClements, D. J. & Capanoglu, E. Recent advances on the improvement of quercetin bioavailability. Trends Food Sci. Technol. 119, 192\u2013200. https:\/\/doi.org\/10.1016\/J.TIFS.2021.11.032 (2022).","journal-title":"Trends Food Sci. Technol."},{"issue":"1","key":"63820_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.colsurfb.2011.06.020","volume":"88","author":"M Kakran","year":"2011","unstructured":"Kakran, M., Sahoo, N. G. & Li, L. Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf. B 88 (1), 121\u2013130. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.06.020 (2011).","journal-title":"Colloids Surf. B"},{"key":"63820_CR18","unstructured":"Abd El-Rahman, S., Suhailah, S. & Al-jameel, S. Quercetin nanoparticles: preparation and characterization. 96\u2013103 (2014)."},{"issue":"1","key":"63820_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","volume":"231","author":"VS Fernandes","year":"2012","unstructured":"Fernandes, V. S. et al. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease. Behav. Brain. Res. 231 (1), 154\u2013163. https:\/\/doi.org\/10.1016\/j.bbr.2012.03.008 (2012).","journal-title":"Behav. Brain. Res."},{"issue":"4","key":"63820_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1021694307672\/METRICS","volume":"29","author":"RE Brown","year":"1999","unstructured":"Brown, R. E., Corey, S. C. & Moore, A. K. Differences in measures of exploration and fear in MHC-congenic C57BL\/6J and B6-H-2K mice. Behav. Genet. 29 (4), 263\u2013271. https:\/\/doi.org\/10.1023\/A:1021694307672\/METRICS (1999).","journal-title":"Behav. Genet."},{"key":"63820_CR21","doi-asserted-by":"publisher","unstructured":"Bandookwala, M. et al. Edaravone-caffeine combination for the effective management of rotenone induced Parkinson\u2019s disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression. Neurosci. Lett.. https:\/\/doi.org\/10.1016\/j.neulet.2019.134438 (2019).","DOI":"10.1016\/j.neulet.2019.134438"},{"issue":"1","key":"63820_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0026-265X(78)90034-6","volume":"23","author":"AE Ciarlone","year":"1978","unstructured":"Ciarlone, A. E. Further modification of a fluorometric method for analyzing brain amines. Microchem. J. 23 (1), 9\u201312. https:\/\/doi.org\/10.1016\/0026-265X(78)90034-6 (1978).","journal-title":"Microchem. J."},{"issue":"6","key":"63820_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0039-128x(94)90006-x","volume":"59","author":"MB Ruiz-Larrea","year":"1994","unstructured":"Ruiz-Larrea, M. B., Leal, A. M., Liza, M., Lacort, M. & de Groot, H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59 (6), 383\u2013388. https:\/\/doi.org\/10.1016\/0039-128x(94)90006-x (1994).","journal-title":"Steroids"},{"issue":"6 Pt 1","key":"63820_CR24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/clinchem\/41.6.892","volume":"41","author":"H Moshage","year":"1995","unstructured":"Moshage, H., Kok, B., Huizenga, J. R. & Jansen, P. L. M. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin. Chem. 41 (6 Pt 1), 892\u2013896. https:\/\/doi.org\/10.1093\/clinchem\/41.6.892 (1995).","journal-title":"Clin. Chem."},{"issue":"1","key":"63820_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"M Moron","year":"1979","unstructured":"Moron, M., Depierre, J. & Mannervik, B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim. Biophys. Acta (BBA) Gen. Subj. 582 (1), 67\u201378. https:\/\/doi.org\/10.1016\/0304-4165(79)90289-7 (1979).","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"issue":"1","key":"63820_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0003-2697(78)90350-0","volume":"86","author":"V Gorun","year":"1978","unstructured":"Gorun, V., Proinov, I., B\u01celtescu, V., Balaban, G. & B\u00e2rzu, O. Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparations. Anal. Biochem. 86 (1), 324\u2013326. https:\/\/doi.org\/10.1016\/0003-2697(78)90350-0 (1978).","journal-title":"Anal. Biochem."},{"issue":"2","key":"63820_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1006\/abio.1996.9911","volume":"244","author":"A Holt","year":"1997","unstructured":"Holt, A., Sharman, D. F., Baker, G. B. & Palcic, M. M. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal. Biochem. 244 (2), 384\u2013392. https:\/\/doi.org\/10.1006\/abio.1996.9911 (1997).","journal-title":"Anal. Biochem."},{"issue":"7","key":"63820_CR28","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/antiox9070597","volume":"9","author":"KH Chang","year":"2020","unstructured":"Chang, K. H. & Chen, C. M. The role of oxidative stress in Parkinson\u2019s Disease. Antioxidants 9 (7), 597. https:\/\/doi.org\/10.3390\/antiox9070597 (2020).","journal-title":"Antioxidants"},{"issue":"5","key":"63820_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","volume":"33","author":"TJ Montine","year":"2002","unstructured":"Montine, T. J. et al. Lipid peroxidation in aging brain and Alzheimer\u2019s disease. Free Radic. Biol. Med. 33 (5), 620\u2013626. https:\/\/doi.org\/10.1016\/S0891-5849(02)00807-9 (2002).","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"63820_CR30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/MED.21712","volume":"41","author":"PR Angelova","year":"2021","unstructured":"Angelova, P. R., Esteras, N. & Abramov, A. Y. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention. Med. Res. Rev. 41 (2), 770\u2013784. https:\/\/doi.org\/10.1002\/MED.21712 (2021).","journal-title":"Med. Res. Rev."},{"issue":"6","key":"63820_CR31","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/J.1471-4159.2006.03907.X","volume":"97","author":"B Halliwell","year":"2006","unstructured":"Halliwell, B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 97 (6), 1634\u20131658. https:\/\/doi.org\/10.1111\/J.1471-4159.2006.03907.X (2006).","journal-title":"J. Neurochem."},{"key":"63820_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.niox.2016.02.001","volume":"54","author":"CT Lee","year":"2016","unstructured":"Lee, C. T., Yu, L. E. & Wang, J. Y. Nitroxide antioxidant as a potential strategy to attenuate the oxidative\/nitrosative stress induced by hydrogen peroxide plus nitric oxide in cultured neurons. Nitric Oxide 54, 38\u201350. https:\/\/doi.org\/10.1016\/j.niox.2016.02.001 (2016).","journal-title":"Nitric Oxide"},{"key":"63820_CR33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neubiorev.2020.10.004","volume":"120","author":"G Bj\u00f8rklund","year":"2021","unstructured":"Bj\u00f8rklund, G., Peana, M., Maes, M., Dadar, M. & Severin, B. The glutathione system in Parkinson\u2019s disease and its progression. Neurosci. Biobehav. Rev. 120, 470\u2013478. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.10.004 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"6","key":"63820_CR34","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor, M. M. & Nelson, A. B. Circuit mechanisms of Parkinson\u2019s Disease. Neuron 101 (6), 1042\u20131056. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.004 (2019).","journal-title":"Neuron"},{"issue":"1","key":"63820_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/brainsci14010100","volume":"14","author":"TB Sampaio","year":"2024","unstructured":"Sampaio, T. B. et al. Exploring Parkinson\u2019s Disease-Associated Depression: Role of inflammation on the noradrenergic and serotonergic pathways. Brain Sci. 14 (1), 100. https:\/\/doi.org\/10.3390\/brainsci14010100 (2024).","journal-title":"Brain Sci."},{"key":"63820_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.yjmcc.2013.12.032","volume":"73","author":"N Kaludercic","year":"2014","unstructured":"Kaludercic, N., Mialet-Perez, J., Paolocci, N., Parini, A. & Di Lisa, F. Monoamine oxidases as sources of oxidants in the heart. J. Mol. Cell. Cardiol. 73, 34\u201342. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.12.032 (2014).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"63820_CR37","doi-asserted-by":"publisher","unstructured":"Aosaki, T., Miura, M., Suzuki, T., Nishimura, K. & Masuda, M. Acetylcholine-dopamine balance hypothesis in the striatum: An update. Geriatr. Gerontol. Int.. https:\/\/doi.org\/10.1111\/J.1447-0594.2010.00588.X (2010).","DOI":"10.1111\/J.1447-0594.2010.00588.X"},{"issue":"1","key":"63820_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-019-0299-4","volume":"41","author":"C Xiao","year":"2020","unstructured":"Xiao, C., Zhou, C., Jiang, J. & Yin, C. Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence. Acta Pharmacol. Sin. 41 (1), 1\u20139. https:\/\/doi.org\/10.1038\/s41401-019-0299-4 (2020).","journal-title":"Acta Pharmacol. Sin."},{"issue":"6521","key":"63820_CR39","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/374450A0","volume":"374","author":"A Acheson","year":"1995","unstructured":"Acheson, A. et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 374 (6521), 450\u2013453. https:\/\/doi.org\/10.1038\/374450A0 (1995).","journal-title":"Nature"},{"key":"63820_CR40","doi-asserted-by":"publisher","unstructured":"Faria, M. C. et al. Increased plasma levels of BDNF and inflammatory markers in Alzheimer\u2019s disease. J. Psychiatr. Res. 53(1), 166\u2013172 (2014). https:\/\/doi.org\/10.1016\/j.jpsychires.2014.01.019","DOI":"10.1016\/j.jpsychires.2014.01.019"},{"issue":"19","key":"63820_CR41","doi-asserted-by":"publisher","first-page":"22666","DOI":"10.18632\/AGING.203598","volume":"13","author":"TKS Ng","year":"2021","unstructured":"Ng, T. K. S. et al. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: A case-control study. Aging 13 (19), 22666\u201322689. https:\/\/doi.org\/10.18632\/AGING.203598 (2021).","journal-title":"Aging"},{"issue":"6","key":"63820_CR42","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1523\/JNEUROSCI.1085-12.2013","volume":"33","author":"A Walczak","year":"2013","unstructured":"Walczak, A. et al. Novel higher-order epigenetic regulation of the Bdnf gene upon seizures. J. Neurosci. 33 (6), 2507\u20132511. https:\/\/doi.org\/10.1523\/JNEUROSCI.1085-12.2013 (2013).","journal-title":"J. Neurosci."},{"issue":"1","key":"63820_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/exnr.2002.7960","volume":"177","author":"E Rousselet","year":"2002","unstructured":"Rousselet, E. et al. Role of TNF-\u03b1 receptors in mice intoxicated with the parkinsonian toxin MPTP. Exp. Neurol. 177 (1), 183\u2013192. https:\/\/doi.org\/10.1006\/exnr.2002.7960 (2002).","journal-title":"Exp. Neurol."},{"issue":"1","key":"63820_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.brainres.2007.02.003","volume":"1147","author":"C Gemma","year":"2007","unstructured":"Gemma, C. et al. Early inhibition of TNF\u03b1 increases 6-hydroxydopamine-induced striatal degeneration. Brain Res. 1147 (1), 240\u2013247. https:\/\/doi.org\/10.1016\/j.brainres.2007.02.003 (2007).","journal-title":"Brain Res."},{"issue":"1","key":"63820_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1046\/J.1471-4159.2002.00799.X","volume":"81","author":"A Casta\u00f1o","year":"2002","unstructured":"Casta\u00f1o, A., Herrera, A. J., Cano, J. & Machado, A. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-\u03b1 IL-1\u03b2 IFN-\u03b3. J. Neurochem. 81 (1), 150\u2013157. https:\/\/doi.org\/10.1046\/J.1471-4159.2002.00799.X (2002).","journal-title":"J. Neurochem."},{"issue":"9","key":"63820_CR46","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1039\/C7TB03053C","volume":"6","author":"Q Han","year":"2018","unstructured":"Han, Q. et al. Quercetin nanoparticles with enhanced bioavailability as multifunctional agents toward amyloid induced neurotoxicity. J. Mater. Chem. B. 6 (9), 1387\u20131393. https:\/\/doi.org\/10.1039\/C7TB03053C (2018).","journal-title":"J. Mater. Chem. B"},{"key":"63820_CR47","doi-asserted-by":"publisher","unstructured":"Herraiz, T. & Guill\u00e9n, H. Monoamine oxidase-A inhibition and associated antioxidant activity in plant extracts with potential antidepressant actions. BioMed Res. Int. (2018). https:\/\/doi.org\/10.1155\/2018\/4810394.","DOI":"10.1155\/2018\/4810394"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63820-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63820-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:58:14Z","timestamp":1785916694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-63820-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["63820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-63820-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"24149"}}